Vijaya Diagnostic Centre Limited has informed the Exchange regarding Appointment of Mr Ankit Shah as Chief Financial Officer of the company w.e.f. February 13, 2026.

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹991.85

prior close

₹987.45

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.6%+1.1% vs market

Healthcare Service Provider peers, median of 25sector-0.5%-0.0% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Smallcap 250 and in line with its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-1.6+1.1-0.5-0.0

Next day

+1.6-1.7+3.3-0.3+2.0

+3.0-0.9+4.0-1.2+4.3

+2.4-0.4+2.9-0.6+3.0

+2.0-1.6+3.6-2.1+4.1

+1.7-1.8+3.5-1.4+3.1

-0.3-2.0+1.7-2.1+1.8

15d

-4.6-7.3+2.7-8.5+4.0

-6.0-8.6+2.5-8.5+2.5

-0.6-3.5+2.8-6.4+5.8

+30.3+3.3+27.1-0.7+31.0

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vijaya Diagnostic Centre's board, at its meeting on February 13, 2026, approved the unaudited Q3 FY26 (ended Dec 31, 2025) standalone and consolidated financial results. Mr. S. Ramachandra Reddy stepped down as Chief Financial Officer due to organizational restructuring, but will continue as General Manager – Finance & Accounts. Mr. Ankit Shah, a Chartered Accountant and former Group CFO at Incor Hospitals (OMNI Hospitals), was appointed as the new CFO effective the same date. Two new Non-Executive Independent Directors — senior advocate Mr. Ravi Shankararamiah (DIN 00180746) and senior gynaecologist Dr. Sasikala Paruchuri Kola (DIN 00129614) — were appointed for 5-year terms, subject to shareholder approval. The board also appointed Mr. Sai Prasad (ex-UnitedHealth/Optum) as CTO and Mr. Siva Rama Raju Vegesna (ex-KIMS Hospitals and a former Vijaya employee) as COO. Additionally, 1,15,000 ESOPs were granted at ₹809 per option (a 20% discount to the 3-month average) under the VDCL ESOP Plan 2018, and the Related Party Transaction policy was revised per the latest SEBI framework.

Likely market impact

This is a broad leadership refresh rather than a distress signal — the outgoing CFO stays on, and the new C-suite brings strong healthcare, technology and capital markets expertise. The addition of two experienced independent directors (legal and medical) should strengthen board oversight. Investors should focus on the Q3 results for actual business performance, as leadership transitions are well-managed.